1. Comparison of exercise training and estrogen supplementation on mast cell-mediated doxorubicin-induced cardiotoxicity
   Sukanya Phungphong et al, 2020, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef
2. Endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity may be therapeutically targeted by natural and chemical compounds: A review
   Fatemeh Yarmohammadi et al, 2021, Pharmacological Research CrossRef
3. Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice
   Kevin Agostinucci et al, 2023, Pharmaceuticals CrossRef
4. Potential targets for intervention against doxorubicin-induced cardiotoxicity based on genetic studies: a systematic review of the literature
   Yan Chen et al, 2020, Journal of Molecular and Cellular Cardiology CrossRef
5. Estrone-mediated lowering of ROS and NOX4 improves endothelial function in ovariectomized wistar rats
   Thiago S. Oliveira et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
6. 2-Methoxyestradiol ameliorates doxorubicin-induced cardiotoxicity by regulating the expression of GLUT4 and CPT-1B in female rats
   Mohamed H. Sobhy et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
7. Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats
   Kaytee L. Pokrzywinski et al, 2018, Biology of Sex Differences CrossRef
8. Systematic Evaluations of Doxorubicin-Induced Toxicity in Rats Based on Metabolomics
   Chunmei Geng et al, 2021, ACS Omega CrossRef
9. Protective effect of valsartan against doxorubicin‐induced cardiotoxicity: Histopathology and metabolomics in vivo study
   Khalid Alhazzani et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
10. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats
    Shu-Rong Wang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
11. Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress
    Jiamao Lin et al, 2019, European Journal of Pharmacology CrossRef
12. Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging
    Zachary S. Clayton et al, 2021, Aging and Cancer CrossRef
13. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity
    Sharon A. George et al, 2020, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
14. Korean Red Ginseng enhances cardiac hemodynamics on doxorubicin-induced toxicity in rats
    Young-Jin Jang et al, 2020, Journal of Ginseng Research CrossRef
15. Prophylactic and Ameliorative Effect of N-Acetylcysteine on Doxorubicin-Induced Neurotoxicity in Wister Rats
    Walaa I. Mohammed et al, 2019, Egyptian Journal of Basic and Clinical Pharmacology CrossRef
16. Two‐Dimensional Ultra‐Thin Nanosheets with Extraordinarily High Drug Loading and Long Blood Circulation for Cancer Therapy
    He Zhang et al, 2022, Small CrossRef